Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03TTT
|
|||
Former ID |
DIB009614
|
|||
Drug Name |
AR-00341677
|
|||
Synonyms |
GDC-0879; Anticancer program, Array/Genentech; B-Raf kinase inhibitors (cancer), Array/Genentech
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
Company |
Array BioPharma Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H18N4O2
|
|||
Canonical SMILES |
C1CC(=NO)C2=C1C=C(C=C2)C3=CN(N=C3C4=CC=NC=C4)CCO
|
|||
InChI |
1S/C19H18N4O2/c24-10-9-23-12-17(19(21-23)13-5-7-20-8-6-13)15-1-3-16-14(11-15)2-4-18(16)22-25/h1,3,5-8,11-12,24-25H,2,4,9-10H2/b22-18-
|
|||
InChIKey |
DEZZLWQELQORIU-PYCFMQQDSA-N
|
|||
CAS Number |
CAS 905281-76-7
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
16822009, 23806501, 80606160, 99436996, 103643222, 124757002, 125163807, 126583484, 126634889, 126671631, 126724039, 131480758, 134964406, 136340131, 136367302, 136367934, 136920329, 136946695, 136959527, 137358532, 144116005, 151995972, 152258837, 152344244, 160647688, 162011561, 162037438, 162202587, 172660259, 174531364, 177749154, 180386838, 186022247, 188900392, 201500244, 223388386, 223684964, 223736290, 228576032, 251963966, 251971267, 252158073, 252160166, 252215463
|
|||
ChEBI ID |
CHEBI:91434
|
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5681). | |||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5681). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.